Rocky Mountain Cancer Center is a clinical research site located in Aurora, Colorado, United States 80012.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Center has participated in 11 clinical trials with 3 currently active.
Therapeutic areas: B-cell Lymphoma, Non Hodgkin Lymphoma, Multiple Myeloma.
Sponsors: Sutro Biopharma, Inc., PTC Therapeutics, Gilead Sciences.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Center has 11 clinical trials on record, with 3 currently active. Their work covers B-cell Lymphoma, Non Hodgkin Lymphoma, Multiple Myeloma.
Yes — Rocky Mountain Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.